Pluri creates cell-based products for commercial use and aims to promote global wellbeing and sustainability.

The company's technology platform, a patented and validated 3D cell expansion system, advances novel cell-based solutions for a range of initiatives, from medicine and climate change to food scarcity and animal cruelty.

Pluri's method is accurate, scalable, cost effective, and consistent from batch to batch.

Pluri currently operates in the field of regenerative medicine and food technology and aims to establish partnerships that leverage the company's 3D cell-based technology in additional industries that require effective, mass cell production.